Resources
[MediRama EDGE] A GR Antagonist, LIFYORLI™ (Relacorilant), in Ovarian Cancer: Redefining Chemotherapy Resistance
- Writer:관리자
- Date:2026-05-26
A GR Antagonist, LIFYORLI™ (Relacorilant), in Ovarian Cancer: Redefining Chemotherapy Resistance
송출일 : 2026.05.26
https://www.youtube.com/watch?v=XXZx-fxQKaE